Study of IBI3011 for acute gout flare
Part of Bones, joints & muscles, Pain clinical trials.
This study tests a new medicine called IBI3011 to see if it can reduce pain and inflammation during an acute gout flare. It's for people whose current gout flare treatments haven't worked well or caused side effects.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 75 years old.
- You have had at least 2 gout flares in the past year.
- You are having a gout flare right now (started within the last 4 days).
- Your current gout flare pain is at least 50 out of 100 on a pain scale.
- You cannot take or have not responded well to standard gout flare medicines like colchicine or NSAIDs.
- You are willing to follow the study's treatment plan and use birth control if needed.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new medication, ABP-745, for people having an acute gout flare. It aims to see if the drug is safe and helps reduce pain and inflammation.
This trial tests an oral medication (HRS-2129) to see if it can calm a sudden gout flare and reduce joint pain. It may help if you are currently having a moderate-to-severe gout attack and are otherwise in good health.
This trial tests a new investigational drug called plonmarlimab for people with frequent, painful gout flares who cannot take standard treatments. The goal is to see if it can reduce pain and inflammation from the flare.
This trial tests an experimental drug, SSS11, to see if it is safe and how it affects uric acid levels in people with gout and high uric acid. You may not take other gout medicines during the study.
This study tests a medicine called SSGJ-613 to see if it can reduce gout flares when people start treatment to lower uric acid. It may help people who have frequent gout attacks.
This trial tests a new medicine, IG3018, to lower high uric acid levels in people with or without chronic kidney disease. It aims to find the right dose and see if it's safe.
Hear when a new Acute Gouty Arthritis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.